Incyte to Present at Upcoming Investor Conference

Rhea-AI Summary

Incyte will present at the Evercore ISI 4th Annual HealthCONx Conference (Virtual) on Tuesday, November 30, 2021, at 2:15 p.m. ET. This presentation will be webcast live and accessible at Investor.Incyte.com, with a replay available for 30 days. Based in Wilmington, Delaware, Incyte is a global biopharmaceutical company focused on developing proprietary therapeutics to address serious unmet medical needs.

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq:INCY) announced today that it will present at the Evercore ISI 4^th Annual HealthCONx Conference (Virtual) on Tuesday, November 30, 2021 at 2:15 p.m. ET.

The presentation will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211109005066/en/

Incyte

Media

Catalina Loveman

+1 302 498 6171

cloveman@incyte.com

Investors

Christine Chiou

+1 302 274 4773

cchiou@incyte.com

 

Source: Incyte

FAQ

When is Incyte's presentation at the Evercore ISI HealthCONx Conference?

Incyte's presentation will take place on Tuesday, November 30, 2021, at 2:15 p.m. ET.

How can I access Incyte's presentation from the HealthCONx Conference?

The presentation will be webcast live and can be accessed at Investor.Incyte.com.

Will Incyte's presentation be available for replay?

Yes, the presentation will be available for replay for 30 days after the event.

What is the focus of Incyte as a biopharmaceutical company?

Incyte focuses on finding solutions for serious unmet medical needs through the development of proprietary therapeutics.

Where is Incyte located?

Incyte is based in Wilmington, Delaware.